Angion Biomedica Corp

NASDAQ:ANGN  
3.38
-0.22 (-6.11%)
Other Pre-Announcement

Angion Reports Q3 Loss Per Share Of 53 Cents

Published: 11/12/2021 12:36 GMT
Angion Biomedica Corp (ANGN) - Angion Provides Corporate Update and Reports Third Quarter 2021 Financial Results.
Q3 Loss per Share $0.53.
Expects Current Cash Resources to Be Sufficient to Fund Planned Operations Through End of 2022.